Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

News feed

Fix Price bought 73.2 million shares as part of buyback

12/15/25 FIXR

Shareholders of JSCB Primorye approved the exchange of subordination for additional issue shares

12/15/25 PRMB

Shareholders of Avangard Bank approved dividends

12/15/25 AVAN

KLVZ Kristall registers the Trump brand

12/15/25 KLVZ

SFI has withdrawn from its shareholder value creation program

12/15/25 SFIN

Court granted Rusal's claim against Rio Tinto for ₽100 billion

12/15/25 RUAL

Norilsk Nickel presents a new overview of the metals market

12/15/25 GMKN

Kamaz introduced new Moskvich models

12/15/25 KMAZ

Fesco wants to receive ₽81.5 billion from Ziyavudin Magomedov

12/15/25 FESH

SPB Exchange has launched an over-the-counter placement of shares of the brainbox_I venture fund

12/15/25 OTCI